(Q78174579)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9990680%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

review article

1 reference

title

Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis, and staging (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9990680%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

S A Feig

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9990680%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9990680%20AND%20SRC:MED&resulttype=core&format=json

Seminars in Nuclear Medicine

12 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9990680%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9990680%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9990680%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

3-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9990680%20AND%20SRC:MED&resulttype=core&format=json

Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Deficiencies in the analysis of breast cancer screening data.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Increased benefit from shorter screening mammography intervals for women ages 40-49 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

American Cancer Society guidelines for the early detection of breast cancer: update 1997

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

American College of Radiology guidelines for breast cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Breast Cancer Detection Demonstration Project: five-year summary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

National survey of mammographic facilities in 1985, 1988, and 1992

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Breast cancer screening outcomes in women ages 40-49: clinical experience with service screening using modern mammography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Mammography outcomes in a practice setting by age: prognostic factors, sensitivity, and positive biopsy rate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Analysis of clinically occult and mammographically occult breast tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Determination of mammographic screening intervals with surrogate measures for women aged 40-49 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Analysis of parenchymal density on mammograms in 1353 women 25-79 years old.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Previous mammograms in patients with impalpable breast carcinoma: retrospective vs blinded interpretation. 1993 ARRS President's Award

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Screening for breast cancer: how effective are our tests? A critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Lack of efficacy of thermography as a screening tool for minimal and stage I breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Thermography, mammography, and clinical examination in breast cancer screening. Review of 16,000 studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Lightscanning versus mammography for the detection of breast cancer in screening and clinical practice. A Swedish multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Scintigraphic imaging of breast tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Differentiation between benign and malignant breast lesions with MR imaging and scintimammography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Evaluation of new imaging procedures for breast cancer: proper process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

7 January 2021

MR imaging of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Ten-year risk of false positive screening mammograms and clinical breast examinations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Positive predictive value of breast biopsy performed as a result of mammography: there is no abrupt change at age 50 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Acceptability of periodic follow-up as an alternative to biopsy for mammographically detected lesions interpreted as probably benign

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

The predictive value of certain mammographic signs in screening for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Nonpalpable breast lesions: recommendations for biopsy based on suspicion of carcinoma at mammography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Nonpalpable lesions detected with mammography: review of 512 consecutive cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Nonpalpable, circumscribed, noncalcified solid breast masses: likelihood of malignancy based on lesion size and age of patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Induced costs of low-cost screening mammography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Mammographic features of 300 consecutive nonpalpable breast cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Solid breast nodules: use of sonography to distinguish between benign and malignant lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Management of solid breast nodules: what is the role of sonography?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

Should breast self-examination be included in a mammographic screening program?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980026-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-2998(99)80026-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9990680%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference